Complications of Chickenpox in Bulgaria – Data from a Single-Center Experience

1. Hambleton S. Chickenpox. Curr Opin Infect Dis. 2005; 18(3):235-40.10.1097/01.qco.0000168384.31766.8915864101Search in Google Scholar

2. Soman R, Madan S. Chickenpox: docile or deadly? J Postgrad Med. 2013; 59(2):91-2.10.4103/0022-3859.11380823793306Search in Google Scholar

3. Vázquez M, Cravioto P, Galván F, et al. Varicella and herpes zoster: challenges for public health. Salud Publica Mex. 2017; 59(6):650-656.10.21149/799729451634Search in Google Scholar

4. WHO position paper. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014; 89:265-88.Search in Google Scholar

5. Ministry of Health of Bulgaria, NCIPD, Available from: https://ncipd.org/index.php?lan=bgSearch in Google Scholar

6. National Statistical Institute, Bulgaria, Available from: https://www.nsi.bg/en/node/1125Search in Google Scholar

7. Komitova R, Boev I, Kazakova Z, et al. Varicella complications-could we do more? Arch Dis Childhood. 2014; 99:A308.10.1136/archdischild-2014-307384.850Search in Google Scholar

8. Gantcheva G. Chickenpox - clinical course, treatment and prevention. Medinfo. 2012; 10:27-32 (article in Bulgarian).Search in Google Scholar

9. Gantcheva G, Doichinova Ts, Simova I, et al. Clinical-laboratory and epidemiological characteristics of chickenpox in the Pleven region. Medinfo. 2008; 10:32-37 (article in Bulgarian).Search in Google Scholar

10. Banadyha N, Rogalskyy I, Komorovsky R. Chickenpox in adults – clinical management. J Infect. 2008; 57(2):95-102.10.1016/j.jinf.2008.03.00418555533Search in Google Scholar

11. Leonid I, Evelyn L. Primary varicella in an immunocompetent adult. J Clin Aesthet Dermatol. 2009; 2:36-38.Search in Google Scholar

12. Jaeggi A, Zurbruegg RP, Aebi C. Complications of varicella in a defined central European population. Arch Dis Child 1998; 79:472-477.10.1136/adc.79.6.472171776010210989Search in Google Scholar

13. Widgren K, Giesecke J, Lindquist L, et al. The burden of chickenpox disease in Sweden. BMC Infect Dis. 2016; 16: 666.10.1186/s12879-016-1957-5510348027832745Search in Google Scholar

14. Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014; (12): 3594-3600.10.4161/hv.34426451404025483695Search in Google Scholar

15. Mészner Z, Wysocki J, Richter D, et al. Burden of varicella in Central and Eastern Europe: findings from a systematic literature review. Expert Rev Vaccines. 2019; (3):281-293.10.1080/14760584.2019.157314530810402Search in Google Scholar

16. Sergamumo Užkrečiamosiomis Ligomis Lietuvoje 2016 M. Apžvalga (Incidence of infectious diseases in Lithuania in 2016: overview). Available from: http://www.ulac.lt/uploads/downloads/en_sergamumo_katalogas/2016_en/Sergamumo_apzvalga_2016.pdfSearch in Google Scholar

17. Vazquez M, LaRussa PS, Gershon AA, et al. Effectiveness over time of varicella vaccine. JAMA : the journal of the American Medical Association 2004; 291: 851-5.10.1001/jama.291.7.85114970064Search in Google Scholar

18. Baxter R, Ray P, Tran TN, et al. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study. Pediatrics 2013; 131: e1389-96.10.1542/peds.2012-330323545380Search in Google Scholar

19. Marin M, Guris D, Chaves S, et al. Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.Search in Google Scholar

20. Seward J, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008; 197 Suppl 2: S82-9.10.1086/52214518419415Search in Google Scholar